These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 17762536
1. Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder. El Kinge AR, Mahfouz RA, Shamseddine AI, Taher AT. Blood Coagul Fibrinolysis; 2007 Sep; 18(6):577-9. PubMed ID: 17762536 [Abstract] [Full Text] [Related]
2. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery. Daniloś J, Goral A, Paluszkiewicz P, Przesmycki K, Kotarski J. Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520 [Abstract] [Full Text] [Related]
3. Intraoperative use of recombinant activated factor VII (rFVIIa). De Gasperi A. Minerva Anestesiol; 2006 Jun; 72(6):489-94. PubMed ID: 16682921 [Abstract] [Full Text] [Related]
4. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding. Hirasaki Y, Suematsu Y, Yasuda T, Tajima K. Anesth Analg; 2010 Jan 01; 110(1):261-2. PubMed ID: 20023190 [No Abstract] [Full Text] [Related]
5. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review. Jirapinyo M, Manonai J, Herabutya Y, Chuncharunee S. J Med Assoc Thai; 2007 May 01; 90(5):977-81. PubMed ID: 17596055 [Abstract] [Full Text] [Related]
6. Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report. Marson F, Farnia A, Callegher L, Casagrande L, Surdu M, Sarpellon M. Minerva Anestesiol; 2006 May 01; 72(7-8):675-82. PubMed ID: 16865086 [Abstract] [Full Text] [Related]
7. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P. Ann Thorac Surg; 2008 Mar 01; 85(3):836-44. PubMed ID: 18291152 [Abstract] [Full Text] [Related]
8. [Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors]. Kawasaki Y, Saeki N, Kawamoto M, Yuge O, Fujii T. Masui; 2005 Aug 01; 54(8):926-8. PubMed ID: 16104555 [Abstract] [Full Text] [Related]
9. Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S. Asian Cardiovasc Thorac Ann; 2012 Feb 01; 20(1):19-23. PubMed ID: 22371937 [Abstract] [Full Text] [Related]
10. Use of recombinant activated factor VII in a patient with severe thrombocytopenia due to myelodysplastic syndrome with uncontrolled gastrointestinal bleeding. Ozcelik T, Ozkocaman V, Ozkalemkas F, Ali R, Altundal Y, Ozkan A, Tunali A. Blood Coagul Fibrinolysis; 2007 Jun 01; 18(4):385-6. PubMed ID: 17473584 [No Abstract] [Full Text] [Related]
11. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K. Pediatr Hematol Oncol; 2008 Jun 01; 25(4):301-11. PubMed ID: 18484474 [Abstract] [Full Text] [Related]
12. Recombinant factor VIIa for the prophylaxis of perioperative hemorrhage in a patient with congenital factor XI deficiency undergoing brain tumor neurosurgery. Sucker C, Sabel M, Stummer W, Zotz RB, Scharf RE, Gerhardt A. Clin Appl Thromb Hemost; 2008 Oct 01; 14(4):472-5. PubMed ID: 18160590 [Abstract] [Full Text] [Related]
13. The use of recombinant-activated factor VII to successfully control postoperative critical bleeding after emergency repair of ruptured abdominal aortic aneurysm in a noncoagulopathic patient. Dell'Utri D, Passariello M. J Cardiothorac Vasc Anesth; 2006 Aug 01; 20(4):570-2. PubMed ID: 16884992 [No Abstract] [Full Text] [Related]
14. Recombinant activated factor VII in the management of massive obstetric bleeding. Palomino MA, Chaparro MJ, de Elvira MJ, Curiel EB. Blood Coagul Fibrinolysis; 2006 Apr 01; 17(3):226-7. PubMed ID: 16575264 [No Abstract] [Full Text] [Related]
15. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia]. Gielen-Wijffels SE, van Mook WN, Ramsay G. Ned Tijdschr Geneeskd; 2003 Mar 01; 147(9):419. PubMed ID: 12661464 [No Abstract] [Full Text] [Related]
16. [Activated recombinant factor VII for bleeding after a kidney transplant: reflections]. Pajares A, Larrea L. Rev Esp Anestesiol Reanim; 2006 Apr 01; 53(4):266-7; author reply 268. PubMed ID: 16711505 [No Abstract] [Full Text] [Related]
17. Recombinant factor VIIa. An update on its clinical use. Franchini M, Zaffanello M, Veneri D. Thromb Haemost; 2005 Jun 01; 93(6):1027-35. PubMed ID: 15968384 [Abstract] [Full Text] [Related]
18. The use of recombinant activated factor VII in the circumcision operation in the case of a congenital factor VII deficiency. Canatan D, Eren E, Ozgüner IF, Duman H, Eren C, Büyükyavuz I, Savaş C. Blood Coagul Fibrinolysis; 2007 Jun 01; 18(4):375-6. PubMed ID: 17473581 [Abstract] [Full Text] [Related]
19. The use of recombinant activated factor VII in platelet-associated bleeding. Franchini M, Lippi G, Guidi GC. Hematology; 2008 Feb 01; 13(1):41-5. PubMed ID: 18534065 [Abstract] [Full Text] [Related]
20. Prophylactic and therapeutic use of recombinant activated factor VII in patients with cirrhosis and coagulation impairment. Tsochatzis E, Papatheodoridis GV, Elefsiniotis I, Thanelas S, Theodossiades G, Moulakakis A, Archimandritis AJ. Dig Liver Dis; 2007 May 01; 39(5):490-4. PubMed ID: 16787769 [Abstract] [Full Text] [Related] Page: [Next] [New Search]